240 related articles for article (PubMed ID: 12239312)
1. Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization.
Guyader M; Kiyokawa E; Abrami L; Turelli P; Trono D
J Virol; 2002 Oct; 76(20):10356-64. PubMed ID: 12239312
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts.
Graham DR; Chertova E; Hilburn JM; Arthur LO; Hildreth JE
J Virol; 2003 Aug; 77(15):8237-48. PubMed ID: 12857892
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains.
Brügger B; Krautkrämer E; Tibroni N; Munte CE; Rauch S; Leibrecht I; Glass B; Breuer S; Geyer M; Kräusslich HG; Kalbitzer HR; Wieland FT; Fackler OT
Retrovirology; 2007 Oct; 4():70. PubMed ID: 17908312
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
Popik W; Alce TM; Au WC
J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
[TBL] [Abstract][Full Text] [Related]
5. Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells.
Liao Z; Graham DR; Hildreth JE
AIDS Res Hum Retroviruses; 2003 Aug; 19(8):675-87. PubMed ID: 13678470
[TBL] [Abstract][Full Text] [Related]
6. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
Yonezawa A; Cavrois M; Greene WC
J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
[TBL] [Abstract][Full Text] [Related]
7. The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity.
Campbell S; Gaus K; Bittman R; Jessup W; Crowe S; Mak J
J Virol; 2004 Oct; 78(19):10556-65. PubMed ID: 15367622
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol depletion inactivates XMRV and leads to viral envelope protein release from virions: evidence for role of cholesterol in XMRV infection.
Tang Y; George A; Taylor T; Hildreth JE
PLoS One; 2012; 7(10):e48013. PubMed ID: 23110160
[TBL] [Abstract][Full Text] [Related]
9. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
Zhou J; Aiken C
J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 6 envelope cholesterol is required for virus entry.
Huang H; Li Y; Sadaoka T; Tang H; Yamamoto T; Yamanishi K; Mori Y
J Gen Virol; 2006 Feb; 87(Pt 2):277-285. PubMed ID: 16432012
[TBL] [Abstract][Full Text] [Related]
11. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
Kamiyama H; Yoshii H; Tanaka Y; Sato H; Yamamoto N; Kubo Y
Virology; 2009 Mar; 386(1):23-31. PubMed ID: 19178925
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts.
Chung CS; Huang CY; Chang W
J Virol; 2005 Feb; 79(3):1623-34. PubMed ID: 15650188
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol dependence of varicella-zoster virion entry into target cells.
Hambleton S; Steinberg SP; Gershon MD; Gershon AA
J Virol; 2007 Jul; 81(14):7548-58. PubMed ID: 17494071
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
Schaeffer E; Geleziunas R; Greene WC
J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
[TBL] [Abstract][Full Text] [Related]
15. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity.
Campbell SM; Crowe SM; Mak J
AIDS; 2002 Nov; 16(17):2253-61. PubMed ID: 12441796
[TBL] [Abstract][Full Text] [Related]
16. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
Kozak SL; Heard JM; Kabat D
J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
[TBL] [Abstract][Full Text] [Related]
17. Virion-targeted viral inactivation: new therapy against viral infection.
Okui N; Kitamura Y; Kobayashi N; Sakuma R; Ishikawa T; Kitamura T
Mol Urol; 2001; 5(2):59-66. PubMed ID: 11690549
[TBL] [Abstract][Full Text] [Related]
18. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
Madani N; Kabat D
J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
[TBL] [Abstract][Full Text] [Related]
19. Requirement of cholesterol in the viral envelope for dengue virus infection.
Carro AC; Damonte EB
Virus Res; 2013 Jun; 174(1-2):78-87. PubMed ID: 23517753
[TBL] [Abstract][Full Text] [Related]
20. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection.
Aizaki H; Morikawa K; Fukasawa M; Hara H; Inoue Y; Tani H; Saito K; Nishijima M; Hanada K; Matsuura Y; Lai MM; Miyamura T; Wakita T; Suzuki T
J Virol; 2008 Jun; 82(12):5715-24. PubMed ID: 18367533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
